Respiratory survey, from Boehringer Ingelheim

WHEN CONSIDERING IDIOPATHIC PULMONARY FIBROSIS (IPF) PATIENTS...

Which of the following statements do you agree with most? (choose one)

FVC: forced vital capacity; ILD: interstitial lung disease.

Find out what your peers said and more.
Switch on here for more information.

DAYS FROM SUSPICION TO REFERRAL

Time is critical in Idiopathic Pulmonary Fibrosis (IPF)

Switch on to early referral

There are specialist interstitial lung disease (ILD) centres across the UK specifically equipped to manage IPF patients. Early referral gives your patients the best chance of living longer while avoiding potentially inappropriate treatments which may be harmful or ineffective. Act now, refer early.1–4

Once in a specialist ILD centre, patients can access anti-fibrotic treatments like OFEV® (nintedanib), which has been proven to reduce the rate of lung-function loss.5–7

PROMOTIONAL CONTENT INITIATED AND PAID FOR BY BOEHRINGER INGELHEIM UK. THIS WEBSITE IS INTENDED FOR UK HEALTH PROFESSIONALS ONLY. PRESCRIBING INFORMATION